✦ LIBER ✦

Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement

✍ Scribed by Keun-Wook Lee; Jongyoun Yi; In Sil Choi; Jee Hyun Kim; Soo-Mee Bang; Dong-Wan Kim; Seock-Ah Im; Tae-You Kim; Sung-Soo Yoon; Jong Seok Lee; Yung-Jue Bang; Seonyang Park; Byoung Kook Kim; Han Ik Cho; Dae Seog Heo

Publisher: Springer
Year: 2009
Tongue: English
Weight: 443 KB
Volume: 88
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-008-0682-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diffuse large B-cell lymphoma with conco

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome

✍ Ekaterina Chigrinova; Michael Mian; Marta Scandurra; Timothy C. Greiner; Wing C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB

## Abstract Bone marrow (BM) involvement in diffuse large B‐cell lymphoma (DLBCL) can be morphologically discordant from the primary tumor. Concordant BM infiltration has been shown associated with a poorer outcome in patients treated with CHOP. In order to evaluate tumor‐related factors leading to

LACE-conditioned autologous stem cell tr

LACE-conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: treatment outcome and risk factor analysis from a single centre

✍ Jiří Pavlů; Holger W. Auner; Sarah Ellis; Richard M. Szydlo; Chrissy Giles; Alej 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is a recognized treatment option for patients with relapsed diffuse large B-cell lymphoma. We have analysed 51 patients who underwent ASCT after LACE (lomustine (CCNU), cytarabine (Ara-C), cyclophosphamide, etoposide) con

Intravenous methotrexate as central nerv

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Kacey O'Rourke; Kirk Morris; Glen A. Kennedy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

Intravenous methotrexate as central nerv

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Jeremy S. Abramson; Matthew Hellmann; Jeffrey A. Barnes; Peter Hammerman; Christ 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

Reply to intravenous methotrexate as cen

Reply to intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Jeremy S. Abramson; Ephraim P. Hochberg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

I read with great interest the article by Cooperberg and coworkers 1 studying survival rates in differently treated men with early prostate cancer. In this study, patients who underwent radical prostatectomy had a substantially decreased disease-specific mortality, particularly in the higher-risk gr